NCT05632523View on ClinicalTrials.gov

Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

November 6, 2024

Study Completion Date

November 6, 2024

Conditions
Renal TransplantConversion
Interventions
OTHER

Blood sample

Blood samples are taken at each visit to the day hospital for a programmed belatacept perfusion

OTHER

urinary sample

Urinary samples are taken at each visit to the day hospital for a programmed belatacept perfusion

Trial Locations (1)

37000

University hospital, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT05632523 - Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients | Biotech Hunter | Biotech Hunter